Last reviewed · How we verify
NCT03170011
Biodex Sit2Stand for Individuals With Cardiac Disease
NA trial testing Exercise using the Biodex Sit2Stand Trainer in Coronary Artery Disease. Withdrawn.
15 September 2017
Quick facts
| Lead sponsor | St. Ambrose University |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Start date | 1 June 2017 |
| Primary completion | 15 September 2017 |
| Estimated completion | 15 September 2017 |
Drugs / interventions tested
- Exercise using the Biodex Sit2Stand Trainer
Conditions studied
- Coronary Artery Disease — all drugs for Coronary Artery Disease →
- Frail Elderly Syndrome — all drugs for Frail Elderly Syndrome →
- Heart Failure — all drugs for Heart Failure →
Sponsor
St. Ambrose University
Who can join
Adults 18 to 100, any sex, with Coronary Artery Disease or Frail Elderly Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients with cardiac disease have been shown to have deficits in activities such as standing up from a chair. The Biodex Sit2Stand Trainer is a new device meant to improve sit to stand performance by providing a lifting force through the seat to help the individual stand. The amount of lift can be graded to help improve leg strength, endurance, and function over time. The device has the potential to be a form of training for those in cardiac rehabilitation who have limitations in standing from a chair.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03170011
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Coronary Artery Disease
Currently open trials in the same condition.
- NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
- NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
- NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
- NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
- NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
Other St. Ambrose University trials
Trials by the same sponsor.
- NCT05715112 — Graded Motor Imagery and Fall Risk in Older Adults · completed
- NCT04023435 — Pain Neuroscience Education for Depression · NA · completed
- NCT04394494 — RCT of Motor Imagery of Extension for LBP vs. Exercise · NA · completed
- NCT03760887 — A Follow-up Comparison of Sensory Discrimination in Patients With Low Back Pain · NA · completed
- NCT03758807 — A Follow-up Comparison of Active Versus Passive Manual Therapy in Patients With Low Back Pain · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03170011 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by St. Ambrose University
- Last refreshed: 19 September 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03170011.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing